IHI – Accelerate.eu

Bringing forward the use of Alpha-emitting Isotope Astatine-211

Accelerate.eu is an initiative designed to push the boundaries of cancer therapy research by proposing an innovative radiotheranostic approach using the Isotope Astatine-211 (²¹¹At) as an Alpha emitter.

With promising physical and chemical properties, ²¹¹At offers several advantages as an Alpha-emitting Radioisotope that could be effective at treating cancers that are resistant to standard treatments such as chemotherapy. This project will focus on three highly aggressive cancers, in the pancreas, breast (triple negative breast cancer) and brain (glioblastoma).

Led by Ion Beam Applications (IBA) and Jules Bordet Institute, Accelerate.eu is a collaboration of 17 European institutions from 9 countries, uniting academic and industrial expertise to transform radiotheranostic therapy. The project aims to develop and test new therapeutic agents, and to ensure a robust and sustainable infrastructure for ²¹¹At production.

Supporting Cancer Care through European Research Projects Collaboration

The Oncidium foundation is proud to be actively part of two innovative projects led by Innovative Health Initiative (IHI)* and the European Commission and focused on advancing precision Oncology and Theranostics in Europe, Accelerate.eu and Thera4Care.

In these two projects, Oncidium is focusing on emphasizing patient advocacy, leveraging its ambassador network and patient-centered vision, to ensure the dissemination of the project’s results within the patient and Oncology communities.

Through these efforts, the foundation reinforces its commitment to expanding access to innovative radiotheranostic solutions and improving cancer care globally.

¹The Innovative Health Initiative (IHI) is a public-private partnership (PPP) between the European Union and the European life science industries. IHI’s mission is to translate health research and innovation into tangible benefits for patients and society, and ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research (www.ihi.europa.eu).

Our Team